Fig 1.
Flow diagram illustrating study procedures, individuals tested and outcomes of testing.
Fig 2.
Hepatitis C seroprevalence by age-group based on anti-HCV rapid diagnostic testing.
Age groups: 12–19 (n = 350), 20–29 (n = 352), 30-39(n = 360), 40-49(n = 301), 50-59(n = 179), 60-69(n = 82), 70+ (n = 66).
Table 1.
Seroprevalence of HCV by demographic information and risk factors.
Table 2.
Multivariate logistic regression analysis of risk factors associated with positive anti-HCV result.